J. Hare
Molecular Biology · New England Journal of Medicine · 2000–2020
A researcher in the Science corpus: 16 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 96 citations into it
- Nephrology — 18 citations into it
- Physiology — 10 citations into it
Whom J. Hare trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Harrison (in Molecular Biology)
Papers from J. Hare's perspective
Ordered by how strongly the researchers J. Hare trusts endorse each paper. Same corpus, a different order for every researcher.
- Bone marrow cells regenerate infarcted myocardium (Nature)
- Adult cardiac stem cells are multipotent and support myocardial regeneration. (Cell)
- Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury (Nature Medicine)
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. (Blood)
- Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone (Proceedings of the National Academy of Sciences of the United States of America)
- Paracrine mechanisms in adult stem cell signaling and therapy (Circulation Research)
- Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion (Nature)
- Transcoronary transplantation of progenitor cells after myocardial infarction. (New England Journal of Medicine)
- Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling (Circulation Research)
- Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. (Journal of Clinical Investigation)
Their papers
- Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications (2004) — 946 citations
- Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation (2010) — 713 citations
- Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy (2012) — 1,194 citations
- A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. (2009) — 1,334 citations
- Myocarditis and inflammatory cardiomyopathy: current evidence and future directions (2020) — 1,017 citations
- Mesenchymal stem cell perspective: cell biology to clinical progress (2019) — 1,639 citations
- FGF23 induces left ventricular hypertrophy. (2011) — 1,899 citations
- Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. (2011) — 868 citations
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity (2009) — 617 citations
- Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (2005) — 1,116 citations
- Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. (2005) — 1,102 citations
- Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. (2003) — 663 citations
- In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction (2003) — 744 citations
- Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (2000) — 1,517 citations
- Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. (2000) — 816 citations
- Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block (2000) — 790 citations